Researchers, clinicians, and public health experts from around the world came together at ISPPD-14 2026 to advance the understanding and prevention of pneumococcal disease and pneumonia, and CHRF was proud to contribute research from Bangladesh.

Our team shared findings on changes in pneumococcal serotype distribution and antimicrobial resistance (AMR) trends over the past 20 years, characteristics of pneumococcus in patients with pleural effusion, and immunological responses to PCV10 in term and preterm infants explored through single-cell genomics.

We are happy to be part of a global community working together to strengthen evidence and advance solutions against pneumococcal disease.